Literature DB >> 7737180

Carbohydrate structure analysis of batroxobin, a thrombin-like serine protease from Bothrops moojeni venom.

G Lochnit1, R Geyer.   

Abstract

The carbohydrate side chains of batroxobin were liberated from tryptic glycopeptides by treatment with peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase F, pyridylaminated and separated by two-dimensional HPLC. Neutral oligosaccharide derivatives obtained after desialylation were characterized by methylation analysis, liquid secondary-ion mass spectrometry, digestion with exoglycosidases and endoglycosidases and, in part, by acetolysis, whereas sialic acid constituents were identified by reverse-phase HPLC after conjugation with 1,2-diamino-4,5-methylene-dioxybenzene. The overall glycosylation status of the protein was studied by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). The results revealed that batroxobin is heterogeneously glycosylated carrying predominantly diantennary, partially incomplete complex-type glycans in addition to hybrid-type species. Most glycans were core-fucosylated at C6 of the innermost GlcNAc. As a characteristic feature, galactose was completely replaced by GalNAc beta 4-substituents in complex-type antennae, the GlcNAc-residues of which were, in part, fucosylated at C3. Furthermore, evidence was obtained that suggested the presence of a novel type of glycoprotein-N-glycan comprising two GalNAc beta 4GlcNAc beta 4GlcNAc beta 2Man-antennae. Sialic acid residues represented a mixture of N-acetylneuraminic acid (Neu5Ac) and N-acetyl-4-O-acetylneuraminic acid (Neu4,5Ac2), which were exclusively linked to C3 of subterminal GalNAc. A precise assignment of these sialic acid derivatives to distinct oligosaccharide structures or antennae, however, was not carried out. Finally, MALDI-TOF-MS demonstrated that both potential N-glycosylation sites of batroxobin are substituted by carbohydrate chains. In conclusion, our studies revealed that this snake venom glycoprotein is characterized by a unique oligosaccharide pattern partly comprising novel structural elements.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737180

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Enzymatic 4-O-acetylation of N-acetylneuraminic acid in guinea-pig liver.

Authors:  M Iwersen; V Vandamme-Feldhaus; R Schauer
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

2.  Characterisation of the enzymatic 4-O-acetylation of sialic acids in microsomes from equine submandibular glands.

Authors:  J Tiralongo; H Schmid; R Thun; M Iwersen; R Schauer
Journal:  Glycoconj J       Date:  2000-12       Impact factor: 2.916

3.  Effective one-pot multienzyme (OPME) synthesis of monotreme milk oligosaccharides and other sialosides containing 4-O-acetyl sialic acid.

Authors:  Hai Yu; Jie Zeng; Yanhong Li; Vireak Thon; Baojun Shi; Xi Chen
Journal:  Org Biomol Chem       Date:  2016-08-22       Impact factor: 3.876

4.  Structures of N-Glycans of Bothrops Venoms Revealed as Molecular Signatures that Contribute to Venom Phenotype in Viperid Snakes.

Authors:  Débora Andrade-Silva; David Ashline; Thuy Tran; Aline Soriano Lopes; Silvia Regina Travaglia Cardoso; Marcelo da Silva Reis; André Zelanis; Solange M T Serrano; Vernon Reinhold
Journal:  Mol Cell Proteomics       Date:  2018-05-01       Impact factor: 5.911

Review 5.  Glycan labeling strategies and their use in identification and quantification.

Authors:  L R Ruhaak; G Zauner; C Huhn; C Bruggink; A M Deelder; M Wuhrer
Journal:  Anal Bioanal Chem       Date:  2010-03-12       Impact factor: 4.142

6.  Batroxobin accelerated tissue repair via neutrophil extracellular trap regulation and defibrinogenation in a murine ischemic hindlimb model.

Authors:  Haruchika Masuda; Atsuko Sato; Tomoko Shizuno; Keiko Yokoyama; Yusuke Suzuki; Masayoshi Tokunaga; Takayuki Asahara
Journal:  PLoS One       Date:  2019-08-16       Impact factor: 3.240

Review 7.  Post-Glycosylation Modification of Sialic Acid and Its Role in Virus Pathogenesis.

Authors:  Simon S Park
Journal:  Vaccines (Basel)       Date:  2019-11-01

8.  Correlation between the glycan variations and defibrinogenating activities of acutobin and its recombinant glycoforms.

Authors:  Ying-Ming Wang; Inn-Ho Tsai; Jin-Mei Chen; An-Chun Cheng; Kay-Hooi Khoo
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

9.  The in situ distribution of glycoprotein-bound 4-O-Acetylated sialic acids in vertebrates.

Authors:  Maria Aamelfot; Ole Bendik Dale; Simon Chioma Weli; Erling Olaf Koppang; Knut Falk
Journal:  Glycoconj J       Date:  2014-05-16       Impact factor: 2.916

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.